ID: ALA4589188

Max Phase: Preclinical

Molecular Formula: C6H6N4

Molecular Weight: 134.14

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  Nc1nc2ncccc2[nH]1

Standard InChI:  InChI=1S/C6H6N4/c7-6-9-4-2-1-3-8-5(4)10-6/h1-3H,(H3,7,8,9,10)

Standard InChI Key:  KXQPVJRJUJJWQJ-UHFFFAOYSA-N

Associated Targets(Human)

7,8-dihydro-8-oxoguanine triphosphatase 280 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Beta-secretase 1 15641 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 134.14Molecular Weight (Monoisotopic): 134.0592AlogP: 0.54#Rotatable Bonds: 0
Polar Surface Area: 67.59Molecular Species: NEUTRALHBA: 3HBD: 2
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 11.33CX Basic pKa: 5.59CX LogP: 0.22CX LogD: 0.22
Aromatic Rings: 2Heavy Atoms: 10QED Weighted: 0.55Np Likeness Score: -0.74

References

1. Wiedmer L, Schärer C, Spiliotopoulos D, Hürzeler M, Śledź P, Caflisch A..  (2019)  Ligand retargeting by binding site analogy.,  175  [PMID:31077996] [10.1016/j.ejmech.2019.04.037]

Source